ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,410Medicare Part D Prescriptions Filled, Including Refills

Rank: 153 out of 617

$381K Total Retail Price of All Prescriptions

Rank: 165 out of 617

436 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,618 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 493 432 1 2
LEVOTHYROXINE SODIUM 402 316 2 1
OMEPRAZOLE 333 253 3 3
AMLODIPINE BESYLATE 249 201 4 6
HYDROCODONE-ACETAMINOPHEN 242 211 S3 5 8
LISINOPRIL 235 172 6 5
METOPROLOL SUCCINATE 196 178 7 12
WARFARIN SODIUM 171 153 8 7
POTASSIUM CHLORIDE 167 140 9 10
ALENDRONATE SODIUM 161 140 10 25
ZOLPIDEM TARTRATE 140 119 11 23
ATORVASTATIN CALCIUM 132 103 12 14
METFORMIN HCL 131 98 13 9
FUROSEMIDE 131 98 13 4
MELOXICAM 125 108 15 24
PANTOPRAZOLE SODIUM 111 89 16 37
HYDROCHLOROTHIAZIDE 108 86 17 13
GLIMEPIRIDE 108 85 17 33
METOPROLOL TARTRATE 105 87 19 11
TRAMADOL HCL 94 74 20 15
AZITHROMYCIN 90 68 21 70
CIPROFLOXACIN HCL 89 76 22 60
ATENOLOL 83 73 23 17
TAMSULOSIN HCL 78 71 24 26
VESICARE 77 51 25 95
GABAPENTIN 77 56 25 16
TRIAMTERENE-HCTZ 75 63 27 47
AMITRIPTYLINE HCL 75 38 R 27 56
PROAIR HFA 75 43 27 75
BUMETANIDE 72 54 30 124
PREDNISONE 71 62 31 31
DILTIAZEM ER 63 47 32 81
CEPHALEXIN 61 43 33 68
FLUOXETINE HCL 59 46 34 73
BENICAR 58 38 35 177
DICLOFENAC SODIUM 58 44 35 98
CYCLOBENZAPRINE HCL 54 18 R 37 74
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 32 38 91
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 39 39 29
ALLOPURINOL 50 50 39 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.